Related Experiment Video
Updated: Feb 22, 2026
A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer
Published on: December 26, 2016
Murine model of hepatic breast cancer
Rishi Rikhi1, Elizabeth M Wilson2, Olivier Deas3
1Children's Cancer Therapy Development Institute, Fort Collins, CO 80524, USA.
Background And Aims:
Breast cancer is the most common cancer in women and the second leading cause of cancer-related deaths in this population. Breast cancer related deaths have declined due to screening and adjuvant therapies, yet a driving clinical need exists to better understand the cause of the deadliest aspect of breast cancer, metastatic disease. Breast cancer metastasizes to several distant organs, the liver being the third most common site. To date, very few murine models of hepatic breast cancer exist.
Methods:
In this study, a novel murine model of liver breast cancer using the MDA-MB-231 cell line is introduced as an experimental (preclinical) model.
Results:
Histological typing revealed consistent hepatic breast cancer tumor foci. Common features of the murine model were vascular invasion, lung metastasis and peritoneal seeding.
Conclusions:
The novel murine model of hepatic breast cancer established in this study provides a tool to be used to investigate mechanisms of hepatic metastasis and to test potential therapeutic interventions.
Insights
A new mouse model for liver breast cancer was developed using MDA-MB-231 cells. This preclinical model will aid research into liver metastasis and potential treatments for breast cancer.
Area of Science:
- Oncology
- Translational Research
- Preclinical Models
Background:
- Breast cancer is a leading cause of cancer-related death in women, with metastasis being the deadliest aspect.
- Liver metastasis is common in breast cancer patients, yet few experimental models exist.
- Understanding liver metastasis mechanisms is crucial for improving patient outcomes.
Purpose of the Study:
- To introduce a novel murine model for studying hepatic breast cancer.
- To provide a preclinical tool for investigating liver metastasis.
- To facilitate the testing of new therapeutic strategies for liver metastases.
Main Methods:
- Development of a murine model using the MDA-MB-231 breast cancer cell line.
- Intrahepatic injection or systemic administration of cancer cells to establish liver tumors.
- Histological analysis to confirm tumor formation and characteristics.
Main Results:
- Consistent formation of hepatic breast cancer tumor foci was observed.
- The model exhibited key metastatic features, including vascular invasion.
- Lung metastasis and peritoneal seeding were common occurrences in the model.
Conclusions:
- A novel murine model for hepatic breast cancer has been successfully established.
- This model serves as a valuable tool for studying the mechanisms of liver metastasis.
- The model can be utilized for preclinical evaluation of novel therapeutic interventions against liver breast cancer.
